[Tree] Orthocell's Remplir™ nerve repair treatment on track for US market entry
Version 0.06 (2024-06-10 03:56:29.199000)
updates: Orthocell completes first stage of US market authorization study for Remplir™ Remedi aims to democratize treatments and expand globally
- ➔
- ➔
- ➔
Version 0.05 (2024-03-25 02:22:22.708000)
updates: Orthocell completes first stage of US market authorization study for Remplir™
- ➔
- ➔
Version 0.04 (2024-03-15 11:31:55.654000)
updates: Bioretec's RemeOs Spinal Interbody Cage implant receives FDA breakthrough device status
- ➔
- ➔
Version 0.03 (2024-03-13 02:06:16.515000)
updates: Added information about a new adhesive patch for people with voice disorders
- ➔
Version 0.02 (2024-02-23 22:01:46.277000)
updates: Wireless drug delivery system developed at UNC-Chapel Hill
- ➔
Version 0.01 (2024-01-08 09:56:35.145000)
updates: Includes information about methods for bypassing and treating spinal cord injury
- ➔